Commissioner Califf Touts Use Of EHRs To Help End Clinical Trial Disparities
This article was originally published in The Gray Sheet
Executive Summary
Newly minted FDA Commissioner Robert Califf admitted that electronic health records used to do “a lousy job” of allowing device and drug trial managers to aggregate data from various subgroups, but EHRs have improved and should be tapped for design of pragmatic clinical trials to tease out demographic subgroup data.